| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |